Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)

Description

The goal of this study is to improve our understanding of speech production, and to translate this into medical devices called intracortical brain-computer interfaces (iBCIs) that will enable people who have lost the ability to speak fluently to communicate via a computer just by trying to speak.

Conditions

Anarthria, Dysarthria, Tetraplegia, Spinal Cord Injuries, Amyotrophic Lateral Sclerosis, Brain Stem Infarctions, Locked-in Syndrome, Muscular Dystrophies

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this study is to improve our understanding of speech production, and to translate this into medical devices called intracortical brain-computer interfaces (iBCIs) that will enable people who have lost the ability to speak fluently to communicate via a computer just by trying to speak.

Understanding and Restoring Speech Production Using an Intracortical Brain-computer Interface

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)

Condition
Anarthria
Intervention / Treatment

-

Contacts and Locations

Sacramento

University of California, Davis, Sacramento, California, United States, 95817

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Between 18 and 80 years of age
  • * Clinical diagnosis of spinal cord injury, brainstem stroke, muscular dystrophy, amyotrophic lateral sclerosis or other motor neuron disorders
  • * Complete or incomplete tetraplegia (quadriplegia)
  • * Must live within a three-hour drive of the Study site and geographically stable for at least 15 months after enrollment.
  • * Visual impairment such that extended viewing of a computer monitor would be difficult even with ordinary corrective lenses
  • * Chronic oral or intravenous steroids or immunosuppressive therapy
  • * Other serious disease or disorder that could seriously affect ability to participate in the study

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Leigh R. Hochberg, MD, PhD.,

Sergey Stavisky, Ph.D., PRINCIPAL_INVESTIGATOR, University of California, Davis

Study Record Dates

2027-08-31